Gyon Technologies Capital Management, LP Regenxbio Inc. Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $354,627 - $642,178	18,327 Added 265.92%	25,219 $623,000
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $2.13 Million - $2.97 Million	-86,437 Reduced 92.62%	6,892 $229,000
Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $2.63 Million - $3.51 Million	87,072 Added 1391.59%	93,329 $3.05 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $203,102 - $253,283	6,257 New	6,257 $243,000
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $243,134 - $361,338	-7,234 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $191,845 - $356,997	7,234 New	7,234 $328,000

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.